The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patient preferences for maintenance PARP therapy in ovarian cancer treatment.
 
Laura Jean Havrilesky
Employment - BIOVENTUS (I)
Research Funding - AstraZeneca; Tesaro
 
Stephanie Lim
No Relationships to Disclose
 
Jui-Chen Yang
No Relationships to Disclose
 
Amelia Lorenzo
No Relationships to Disclose
 
Jessie A Ehrisman
No Relationships to Disclose
 
Angeles Alvarez Secord
Honoraria - Alexion Pharmaceuticals; Aravive; Astex Pharmaceuticals; AstraZeneca; Clovis Oncology; Genentech/Roche; Janssen; Merck; Mersana; Myriad Pharmaceuticals; Oncoquest; Tesaro
Consulting or Advisory Role - Alexion Pharmaceuticals; Aravive; Astex Pharmaceuticals; AstraZeneca; Clovis Oncology; Genentech/Roche; Janssen; Merck; Mersana; Myriad Genetics; Oncoquest; Tesaro
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Genentech (Inst); Merck (Inst); PharmaMar (Inst); Prima BioMed (Inst); TapImmune Inc. (Inst); Tesaro (Inst)
 
Reed Johnson
Consulting or Advisory Role - Amgen; Pfizer; Shire; UCB
Research Funding - Abbvie; AstraZeneca; Genzyme; Janssen; Lilly; Lundbeck; Pfizer; Tesaro; Zimmer
 
Shelby D. Reed
Honoraria - Sarepta Therapeutics
Consulting or Advisory Role - Minomic; Novo Nordisk; Regeneron
Research Funding - Abbott; AstraZeneca; Janssen